MedPath

Comparison of RF and crYoballoon ablatiOn Therapy of AF(CRYO-AF)

Not Applicable
Conditions
Atrial Fibrillation
Registration Number
NCT03044951
Lead Sponsor
Ruijin Hospital
Brief Summary

It's a multi-center, prospective, randomized, controlled clinical trial of cryoballoon versus radiofrequency ablation for paroxysmal atrial fibrillation.

Detailed Description

The hypothesis of this study is that pulmonary vein isolation with cryoballoon ablation is not inferior to radiofrequency ablation with 3D mapping with respect to clinical safety and efficacy.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
600
Inclusion Criteria
  • ECG recording of atrial fibrillation
  • first time of ablation
  • refractory to at least one anti-arrhythmia drug
  • sign informed consent for participation in the study
Exclusion Criteria
  • had ablation before
  • serious heart failure
  • left atrial diameter>55mm
  • Myocardial infarction, heart surgery or coronary intervention in 3 months before the ablation
  • Stroke in 6 months before the ablation
  • Endocardial thrombosis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Efficacy endpoint (time to first documented clinical recurrence after blanking period)one year

the time to first documented clinical recurrence after blanking period (month)

Safety endpoint (Any procedure-related complications)one year

Any procedure-related complications

Secondary Outcome Measures
NameTimeMethod
QoL changes at 12 months (Units on a Scale)one year
X-ray time (min)one year
Procedure time (min)one year

skin to skin

Left atrial time (min)one year
time to first time cardiovascular hospitalization (month)one year

Trial Locations

Locations (1)

Shanghai Rui-Jin Hospital, Shanghai JiaoTong University School of Medicine

🇨🇳

Shanghai, Shanghai, China

Shanghai Rui-Jin Hospital, Shanghai JiaoTong University School of Medicine
🇨🇳Shanghai, Shanghai, China
Li-Qun Wu
Contact
wuliqun89@hotmail.com
Tian-You Ling
Contact
lty0919@hotmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.